Effectiveness of Debridement Treatment in Neonatorum Epidermolysis Bullosa: A Case Report

Main Article Content

Azhar Naufaldi Saputra
Nathasya Fernanda
Azmi Alauddin Setyanugrahanto
Ahmad Fawzy Mas'ud

Abstract

Introduction: Epidermolysis Bullosa (EB) is an autosomal genetic disorder that characterized by blistering of the skin and mucosa following mild trauma such as frictional trauma. There is no definitive treatment has yet to be developed. The goal of surgical debridement is to achieve a clean wound bed in fastest way, reduce bacterial burden, remove as much nonvital tissue, speed up the healing process, which will shorten the length of stay in hospital.


Case Finding: We have 3 days old newborn with clinical appearance similar to a second degree burn lesion bullous lesions and epidermal damage on her both feet, gluteal, and genital regions but without previous history of contact with thermal trauma consulted to patients. General physical examination showed no fever and vital within normal condition. In the perinatal history, the baby was delivered by caesarean section from a 37 years-old G3P2A0 mother with preeclampsia comorbid, normal gestational age, her birth weight was 3800 grams, her birth length was 51 cm, and with APGAR her scores of were 9 and 10 the 1st and 5th minute respectively.


Our newborn patient was looked like 2nd degree burn injury with blisters and epidermolysis but without previous history of contact with thermal trauma. Consulted to plastic surgeon for further evaluation and management. The Baby was discharged day 9 or after 3 days debridement management in stable condition.


Conclusion: The surgical debridement demonstrated greatly effective and efficient in achieving these aims. Observation on day 3 did not reveal any sign of infection, showing controlled symptoms and good healing process. We suggest that performing debridement on Epidermolysis Bullosa (EB) patient would shorten the duration of hospitalization. Therefore, it provides low-risk nosocomial infection and low-cost hospitalization.

Article Details

How to Cite
Saputra, A. N., Fernanda, N., Setyanugrahanto, A. A., & Mas’ud, A. F. (2022). Effectiveness of Debridement Treatment in Neonatorum Epidermolysis Bullosa: A Case Report. International Journal of Medical Science and Clinical Research Studies, 2(07), 691–694. https://doi.org/10.47191/ijmscrs/v2-i7-17
Section
Articles
Author Biographies

Azhar Naufaldi Saputra, Medical Doctor, General Practitioner Department, Margono Soekarjo Hospital, Banyumas, Central Java, Indonesia.

Medical doctor, General Practitioner Department, Margono Soekarjo Hospital, Banyumas, Central Java, Indonesia

Nathasya Fernanda, Medical Doctor, Intern of Plastic Surgical Department, Margono Soekarjo Hospital, Banyumas, Central Java, Indonesia.

Medical Doctor, Intern of Plastic Surgery, Margono Soekarjo Hospital, Banyumas, Central Java, Indonesia

Azmi Alauddin Setyanugrahanto, Medical Student, Faculty of Medicine, Jenderal Soedirman University, Banyumas, Central Java, Indonesia.

Medical Student, Faculty of Medicine, Jenderal Soedirman University, Banyumas, Central Java, Indonesia

Ahmad Fawzy Mas'ud, Department of Surgery, Faculty of Medicine, Jenderal Soedirman University, Banyumas, Central Java, Indonesia.

Department of Surgery, Faculty of Medicine, Jenderal Soedirman University, Banyumas, Central Java, Indonesia

References

I. Zhao C, Murrell D. Blistering diseases in neonates. Current Opinion in Pediatrics. 2016;28(4):500-506.

II. Paramanatham P, Sekar S, Maharaja P. Epidermolysis Bullosa in A Neonate-Case Report. Biomedical and Pharmacology Journal. 2016;9(2):533-536.

III. Has C, Bauer J, Bodemer C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. British Journal of Dermatology. 2020;183(4):614-627.

IV. Wakiguchi H, Maeba S, Kimura S, et al. A Sporadic Neonatal Case of Epidermolysis Bullosa Simplex Generalized Intermediate with KRT5 and KRT14 Gene Mutations. American Journal of Perinatology Reports. 2016;06(01):108-111.

V. Secco IL, Costa T, Moraes ELL, et al. Nursing care of a newborn with epidermolysis bullosa: a case report. Revista da Escola de Enfermagem da USP. 2019; 53:03501.

VI. Diefenbeck M, Haustedt N, Schmidt H. Surgical debridement to optimise wound conditions and healing. International Wound Journal. 2013;10(1):43-47.

VII. Hon K, Li J, Cheng B, Luk D, et al. Age and etiology of childhood epidermolysis bullosa mortality. Journal of Dermatological Treatment. 2014;26(2):178-182.

VIII. Price-Douglas W, Diehl-Svrjcek B. Epidermolysis bullosa : A Case Study in Transport, Treatment, and Care. Adv Neonatal Care. 2007;7(6):289–94.

IX. Lara-Corrales I, Arbuckle A, Zarinehbaf S, et al. Principles of wound care in patients with epidermolysis bullosa. Pediatr Dermatol. 2010;27(3):229–237.

X. Huljev D, Gajić A, Triller C, et al. Role of debridement in treatment of chronic wounds. Acta medica Croatica: Časopis Akademije medicinskih znanosti Hrvatske. 2012;66(1):79-84.

XI. Denyer J, Senior EB, Nurse C, et al. The use of debridement pads in the management of children with severe Epidermolysis Bullosa ( EB ). 2013;2013.

XII. Jeon CY, Neidell M, Jia H, Sinisi M, Larson E. On the Role of Length of Stay in Healthcare-Associated Bloodstream Infection. Infect Control Hosp Epidemiol. 2012;33(12):1213–8.

XIII. Zhao CY, Murrell DF. Blistering diseases in neonates. Curr Opin Pediatr. 2016;28(4):500–6.

XIV. Carey K, Lin M-Y. Hospital Length of Stay and Readmission. Med Care Res Rev. 2014;71(1):99–111.